GLEN D MONTEIRO
Allopathic & Osteopathic Physicians|Hospitalist SAN ANTONIO, TX NPI 1598926164
Browse related groups: Allopathic & Osteopathic Physicians|Hospitalist TX Relypsa, Inc. All categories
General Payments — all program years on this page
$317.35
- Category: General Payments
- Program years: PY2018
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $317.35 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $317.35 | 8 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Relypsa, Inc. | $122.54 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $100.62 | 1 |
| Indivior Inc. | $18.68 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.01 | 1 |
| GlaxoSmithKline, LLC. | $17.53 | 1 |
| Circassia Inc. | $13.79 | 1 |
| Lilly USA, LLC | $13.35 | 1 |
| Gilead Sciences, Inc. | $12.83 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $317.35 | 8 |
Records — PY2018 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 559325129 | Lilly USA, LLC | $13.35 | 05/02/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 578590431 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.01 | 11/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 591939037 | Relypsa, Inc. | $122.54 | 06/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 592517805 | Gilead Sciences, Inc. | $12.83 | 07/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 593136879 | Circassia Pharmaceuticals Inc | $13.79 | 05/16/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 594490581 | GlaxoSmithKline, LLC. | $17.53 | 04/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 608528687 | Novartis Pharmaceuticals Corporation | $100.62 | 11/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 615492272 | Indivior Inc. | $18.68 | 02/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.